Literature DB >> 7763044

A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan.

J T Lin1, L Y Wang, J T Wang, T H Wang, C S Yang, C J Chen.   

Abstract

A nested case-control study was carried out to investigate the association between Helicobacter pylori infection and gastric cancer risk in Taiwan. A total of 29 patients newly affected with gastric cancer and 220 healthy controls matched with cases on age, sex and residence were selected from a cohort of 9,775 men recruited from 1984 through 1986. Frozen serum samples collected at recruitment examination were tested for IgG antibodies against Helicobacter pylori by an enzyme-linked immunosorbent assay. The average interval between serum collection and cancer diagnosis was 3.1 years. Gastric cancer cases had a higher seropositive prevalence (69%) than matched controls (59%) giving an odds ratio of 1.6 (95%) confidence interval = 0.7-2.6). Compared with previous nested case-control studies, Helicobacter pylori infection in early childhood may be a risk factor for gastric cancer. However, a long induction period seems required for gastro-carcinogenesis associated with Helicobacter pylori infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7763044

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

1.  Expression of inducible nitric oxide synthase in human gastric cancer.

Authors:  Yu Jun; Guo Fei; Matthias P A Ebert; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  Association between Helicobacter pylori and gastric cancer: current knowledge and future research.

Authors:  Harry Hua-Xiang Xia
Journal:  World J Gastroenterol       Date:  1998-04-15       Impact factor: 5.742

3.  Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone.

Authors:  Yi-Chia Lee; Jyh-Ming Liou; Ming-Shiang Wu; Chun-Ying Wu; Jaw-Town Lin
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

Review 4.  Diet, H pylori infection and gastric cancer: evidence and controversies.

Authors:  Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

5.  Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.

Authors:  Y Watanabe; J H Kurata; S Mizuno; M Mukai; H Inokuchi; K Miki; K Ozasa; K Kawai
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

6.  Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori.

Authors:  H Tabata; T Fuchigami; H Kobayashi; Y Sakai; M Nakanishi; K Tomioka; S Nakamura; M Fujishima
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

7.  Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan.

Authors:  Yu-Lung Chen; Kao-Chi Cheng; Shih-Wei Lai; I-Ju Tsai; Che-Chen Lin; Fung-Chang Sung; Cheng-Chieh Lin; Pei-Chun Chen
Journal:  Gastric Cancer       Date:  2012-10-05       Impact factor: 7.370

8.  Regulation of tumour necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection.

Authors:  J Shibata; H Goto; T Arisawa; Y Niwa; T Hayakawa; A Nakayama; N Mori
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

9.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

10.  Seroprevalence of Helicobacter pylori in school-aged Chinese in Taipei City and relationship between ABO blood groups.

Authors:  Tzee-Chung Wu; Liang-Kung Chen; Shinn-Jang Hwang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.